Premium
Pancreatic Enzyme Replacement Therapy for Enterally Fed Patients With Cystic Fibrosis
Author(s) -
Nicolo Michele,
Stratton Kathleen W.,
Rooney Wanda,
Boullata Joseph
Publication year - 2013
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0884533613491786
Subject(s) - medicine , cystic fibrosis , pancreatic enzymes , enteral administration , parenteral nutrition , enzyme replacement therapy , feeding tube , pancreas , intensive care medicine , gastroenterology , surgery , disease
Administration of pancreatic enzymes (pancrelipase) to adult patients with cystic fibrosis when receiving enteral nutrition through a feeding tube is challenging. A number of techniques for preparing and administering the drug may result in complications that include feeding tube occlusion and inadequate enzyme delivery to the patient. A series of inpatient encounters is described.